Skip to main content
Erschienen in: Journal of Neurology 10/2015

01.10.2015 | Short Commentary

A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia

verfasst von: Anna Bartoletti-Stella, Giacomo Chiaro, Giovanna Calandra-Buonaura, Manuela Contin, Cesa Scaglione, Giorgio Barletta, Annagrazia Cecere, Paolo Garagnani, Paolo Tieri, Alberto Ferrarini, Silvia Piras, Claudio Franceschi, Massimo Delledonne, Pietro Cortelli, Sabina Capellari

Erschienen in: Journal of Neurology | Ausgabe 10/2015

Einloggen, um Zugang zu erhalten

Abstract

Recurrent focal neuropathy with liability to pressure palsies is a relatively frequent autosomal-dominant demyelinating neuropathy linked to peripheral myelin protein 22 (PMP22) gene deletions. The combination of PMP22 gene mutations with other genetic variants is known to cause a more severe phenotype than expected. We present the case of a patient with severe orthostatic hypotension since 12 years of age, who inherited a PMP22 gene deletion from his father. Genetic double trouble was suspected because of selective sympathetic autonomic disturbances. Through exome-sequencing analysis, we identified two novel mutations in the dopamine beta hydroxylase gene. Moreover, with interactome analysis, we excluded a further influence on the origin of the disease by variants in other genes. This case increases the number of unique patients presenting with dopamine-β-hydroxylase deficiency and of cases with genetically proven double trouble. Finding the right, complete diagnosis is crucial to obtain adequate medical care and appropriate genetic counseling.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Chance PF (1999) Overview of hereditary neuropathy with liability to pressure palsies. Ann N Y Acad Sci 883:14–21CrossRefPubMed Chance PF (1999) Overview of hereditary neuropathy with liability to pressure palsies. Ann N Y Acad Sci 883:14–21CrossRefPubMed
4.
Zurück zum Zitat Robertson D, Garland EM, Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K (1993) Dopamine beta-hydroxylase deficiency. In: Seattle, WA (ed) Genereviews, University of Washington, Seattle. Initial Posting: September 4, 2003; Last Update: January 24, 2013 Robertson D, Garland EM, Pagon RA, Adam MP, Bird TD, Dolan CR, Fong CT, Stephens K (1993) Dopamine beta-hydroxylase deficiency. In: Seattle, WA (ed) Genereviews, University of Washington, Seattle. Initial Posting: September 4, 2003; Last Update: January 24, 2013
5.
Zurück zum Zitat Man in ‘t Veld A, Boomsma F, Moleman P, Schalekamp MA (1987) Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome. Lancet 1:183–188PubMed Man in ‘t Veld A, Boomsma F, Moleman P, Schalekamp MA (1987) Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome. Lancet 1:183–188PubMed
6.
Zurück zum Zitat Man in ‘t Veld A, Boomsma F, Lenders J, vd meiracker A, Julien C, Tulen J, Moleman P, Thien T, Lamberts S, Schalekamp M (1988) Patients with congenital dopamine beta-hydroxylase deficiency. A lesson in catecholamine physiology. Am J Hypertens 1:231–238CrossRefPubMed Man in ‘t Veld A, Boomsma F, Lenders J, vd meiracker A, Julien C, Tulen J, Moleman P, Thien T, Lamberts S, Schalekamp M (1988) Patients with congenital dopamine beta-hydroxylase deficiency. A lesson in catecholamine physiology. Am J Hypertens 1:231–238CrossRefPubMed
7.
Zurück zum Zitat Biaggioni I, Goldstein DS, Atkinson T, Robertson D (1990) Dopamine-beta-hydroxylase deficiency in humans. Neurology 40:370–373CrossRefPubMed Biaggioni I, Goldstein DS, Atkinson T, Robertson D (1990) Dopamine-beta-hydroxylase deficiency in humans. Neurology 40:370–373CrossRefPubMed
8.
Zurück zum Zitat Mathias CJ, Bannister RB, Cortelli P, Heslop K, Polak JM, Raimbach S, Springall DR, Watson L (1990) Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline from dopamine because of a deficiency of dopamine beta hydroxylase. Q J Med 75:617–633PubMed Mathias CJ, Bannister RB, Cortelli P, Heslop K, Polak JM, Raimbach S, Springall DR, Watson L (1990) Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline from dopamine because of a deficiency of dopamine beta hydroxylase. Q J Med 75:617–633PubMed
9.
Zurück zum Zitat Gentric A, Fouilhoux A, Caroff M, Mottier D, Jouquan J (1994) Dopamine B hydroxylase deficiency responsible for severe dysautonomic orthostatic hypotension in an elderly patient: clinical experience. J Age Relat Disord 6:7–8 Gentric A, Fouilhoux A, Caroff M, Mottier D, Jouquan J (1994) Dopamine B hydroxylase deficiency responsible for severe dysautonomic orthostatic hypotension in an elderly patient: clinical experience. J Age Relat Disord 6:7–8
10.
Zurück zum Zitat Thompson JM, O’Callaghan CJ, Kingwell BA, Lambert GW, Jennings GL, Esler MD (1995) Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine beta-hydroxylase deficiency. J Auton Nerv Syst 55:198–206CrossRefPubMed Thompson JM, O’Callaghan CJ, Kingwell BA, Lambert GW, Jennings GL, Esler MD (1995) Total norepinephrine spillover, muscle sympathetic nerve activity and heart-rate spectral analysis in a patient with dopamine beta-hydroxylase deficiency. J Auton Nerv Syst 55:198–206CrossRefPubMed
11.
Zurück zum Zitat Scurrah NJ, Ross AW, Solly M (2002) Peripartum management of a patient with dopamine beta-hydroxylase deficiency, a rare congenital cause of dysautonomia. Anaesth Intensive Care 30:484–486PubMed Scurrah NJ, Ross AW, Solly M (2002) Peripartum management of a patient with dopamine beta-hydroxylase deficiency, a rare congenital cause of dysautonomia. Anaesth Intensive Care 30:484–486PubMed
12.
Zurück zum Zitat Kim CH, Zabetian CP, Cubells JF, Cho S, Biaggioni I, Cohen BM, Robertson D, Kim KS (2002) Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am J Med Genet 108:140–147CrossRefPubMed Kim CH, Zabetian CP, Cubells JF, Cho S, Biaggioni I, Cohen BM, Robertson D, Kim KS (2002) Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am J Med Genet 108:140–147CrossRefPubMed
13.
Zurück zum Zitat Garland EM, Raj SR, Demartinis N, Robertson D (2005) Case report: marathon runner with severe autonomic failure. Lancet 366:S13CrossRefPubMed Garland EM, Raj SR, Demartinis N, Robertson D (2005) Case report: marathon runner with severe autonomic failure. Lancet 366:S13CrossRefPubMed
14.
Zurück zum Zitat Deinum J, Steenbergen-Spanjers GC, Jansen M, Boomsma F, Lenders JW, van Ittersum FJ, Hück N, van den Heuvel LP, Wevers RA (2004) DBH gene variants that cause low plasma dopamine beta hydroxylase with or without a severe orthostatic syndrome. J Med Genet 41:e38PubMedCentralCrossRefPubMed Deinum J, Steenbergen-Spanjers GC, Jansen M, Boomsma F, Lenders JW, van Ittersum FJ, Hück N, van den Heuvel LP, Wevers RA (2004) DBH gene variants that cause low plasma dopamine beta hydroxylase with or without a severe orthostatic syndrome. J Med Genet 41:e38PubMedCentralCrossRefPubMed
15.
Zurück zum Zitat Cheshire WP Jr, Dickson DW, Nahm KF, Kaufmann HC, Benarroch EE (2006) Dopamine beta-hydroxylase deficiency involves the central autonomic network. Acta Neuropathol 112:227–229CrossRefPubMed Cheshire WP Jr, Dickson DW, Nahm KF, Kaufmann HC, Benarroch EE (2006) Dopamine beta-hydroxylase deficiency involves the central autonomic network. Acta Neuropathol 112:227–229CrossRefPubMed
16.
Zurück zum Zitat Erez A, Li J, Geraghty MT, Ben-Shachar S, Cooper ML, Mensing DE, Vonalt KD, Ou Z, Pursley AN, Chinault AC, Patel A, Cheung SW, Sahoo T (2010) Mosaic deletion 11p13 in a child with dopamine beta-hydroxylase deficiency-case report and review of the literature. Am J Med Genet A 152A:732–736CrossRefPubMed Erez A, Li J, Geraghty MT, Ben-Shachar S, Cooper ML, Mensing DE, Vonalt KD, Ou Z, Pursley AN, Chinault AC, Patel A, Cheung SW, Sahoo T (2010) Mosaic deletion 11p13 in a child with dopamine beta-hydroxylase deficiency-case report and review of the literature. Am J Med Genet A 152A:732–736CrossRefPubMed
17.
Zurück zum Zitat Despas F, Pathak A, Berry M, Cagnac R, Massabuau P, Liozon E, Galinier M, Senard JM (2010) DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa. Clin Auton Res 20:205–207CrossRefPubMed Despas F, Pathak A, Berry M, Cagnac R, Massabuau P, Liozon E, Galinier M, Senard JM (2010) DBH deficiency in an elderly patient: efficacy and safety of chronic droxidopa. Clin Auton Res 20:205–207CrossRefPubMed
18.
Zurück zum Zitat Kim CH, Leung A, Huh YH, Yang E, Kim DJ, Leblanc P, Ryu H, Kim K, Kim DW, Garland EM, Raj SR, Biaggioni I, Robertson D, Kim KS (2011) Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine beta-hydroxylase. J Biol Chem 286:9196–9204PubMedCentralCrossRefPubMed Kim CH, Leung A, Huh YH, Yang E, Kim DJ, Leblanc P, Ryu H, Kim K, Kim DW, Garland EM, Raj SR, Biaggioni I, Robertson D, Kim KS (2011) Norepinephrine deficiency is caused by combined abnormal mRNA processing and defective protein trafficking of dopamine beta-hydroxylase. J Biol Chem 286:9196–9204PubMedCentralCrossRefPubMed
19.
Zurück zum Zitat Phillips L, Robertson D, Melson MR, Garland EM, Joos KM (2013) Pediatric ptosis as a sign of treatable autonomic dysfunction. Am J Ophthalmol 156:370–374PubMedCentralCrossRefPubMed Phillips L, Robertson D, Melson MR, Garland EM, Joos KM (2013) Pediatric ptosis as a sign of treatable autonomic dysfunction. Am J Ophthalmol 156:370–374PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Guaraldi P, Donadio V, Capellari S, Contin M, Casadio MC, Montagna P, Liguori R, Cortelli P (2011) Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. Auton Neurosci 159:123–126CrossRefPubMed Guaraldi P, Donadio V, Capellari S, Contin M, Casadio MC, Montagna P, Liguori R, Cortelli P (2011) Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. Auton Neurosci 159:123–126CrossRefPubMed
21.
Zurück zum Zitat Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucl Acids Res 37:e67PubMedCentralCrossRefPubMed Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C (2009) Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucl Acids Res 37:e67PubMedCentralCrossRefPubMed
22.
Zurück zum Zitat Yeo G, Burge CB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 11:377–394CrossRefPubMed Yeo G, Burge CB (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 11:377–394CrossRefPubMed
23.
Zurück zum Zitat Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1081CrossRefPubMed Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1081CrossRefPubMed
24.
Zurück zum Zitat Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249PubMedCentralCrossRefPubMed Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Schwarz JM, Rödelsperger C, Schuelke M, Seelow D (2010) MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7:575–576CrossRefPubMed Schwarz JM, Rödelsperger C, Schuelke M, Seelow D (2010) MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7:575–576CrossRefPubMed
26.
27.
Zurück zum Zitat Shihab HA, Gough J, Cooper DN, Stenson PD, Barker GL, Edwards KJ, Day IN, Gaunt TR (2013) Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat 34:57–65PubMedCentralCrossRefPubMed Shihab HA, Gough J, Cooper DN, Stenson PD, Barker GL, Edwards KJ, Day IN, Gaunt TR (2013) Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat 34:57–65PubMedCentralCrossRefPubMed
28.
Zurück zum Zitat Benarroch EE (2013) Monoamine transporters: structure, regulation, and clinical implications. Neurology 81:761–768CrossRefPubMed Benarroch EE (2013) Monoamine transporters: structure, regulation, and clinical implications. Neurology 81:761–768CrossRefPubMed
29.
Zurück zum Zitat Hodapp JA, Carter GT, Lipe HP, Michelson SJ, Kraft GH, Bird TD (2006) Double trouble in hereditary neuropathy: concomitant mutations in the PMP-22 gene and another gene produce novel phenotypes. Arch Neurol 63:112–117CrossRefPubMed Hodapp JA, Carter GT, Lipe HP, Michelson SJ, Kraft GH, Bird TD (2006) Double trouble in hereditary neuropathy: concomitant mutations in the PMP-22 gene and another gene produce novel phenotypes. Arch Neurol 63:112–117CrossRefPubMed
Metadaten
Titel
A patient with PMP22-related hereditary neuropathy and DBH-gene-related dysautonomia
verfasst von
Anna Bartoletti-Stella
Giacomo Chiaro
Giovanna Calandra-Buonaura
Manuela Contin
Cesa Scaglione
Giorgio Barletta
Annagrazia Cecere
Paolo Garagnani
Paolo Tieri
Alberto Ferrarini
Silvia Piras
Claudio Franceschi
Massimo Delledonne
Pietro Cortelli
Sabina Capellari
Publikationsdatum
01.10.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 10/2015
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-015-7896-z

Weitere Artikel der Ausgabe 10/2015

Journal of Neurology 10/2015 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.